| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 275.081.499 $ | +21.025.560 $ | +6,6 % | 10 | 254.055.939 $ | +85.681.398 $ | +56,3 % | 9 | 164.532.702 $ | +33.897.375 $ | +50,8 % | 6 | ||||
| Vaxcyte, Inc. | PCVX | → 0 | Neutral | 79.751.617 $ | +16.427.927 $ | +25,9 % | 1 | 63.323.690 $ | +13.888.941 $ | +28,1 % | 1 | 49.434.749 $ | +7.005.135 $ | +16,5 % | 1 |
| Oculis Holding AG | OCS | → 0 | Stark | 44.678.725 $ | -1.025.775 $ | -2,2 % | 1 | 45.704.500 $ | +5.256.893 $ | +13,0 % | 1 | 40.447.607 $ | -4.210.416 $ | -9,4 % | 1 |
| Evommune, Inc. | EVMN | → 0 | Neutral | 44.300.420 $ | +11.311.156 $ | +34,3 % | 1 | 32.989.264 $ | +32.989.264 $ | 1 | |||||
| Arcutis Biotherapeutics, Inc. | ARQT | → 0 | Neutral | 31.944.816 $ | -7.741.945 $ | -19,5 % | 1 | 39.686.761 $ | -284.815 $ | -0,7 % | 1 | 39.971.576 $ | +10.242.054 $ | +34,5 % | 1 |
| Zenas BioPharma, Inc. | ZBIO | → 0 | Schwach | 11.573.424 $ | -9.921.769 $ | -46,2 % | 1 | 21.495.193 $ | +4.200.394 $ | +24,3 % | 1 | 17.294.799 $ | +9.745.853 $ | +129,1 % | 1 |
| Trevi Therapeutics, Inc. | TRVI | → 0 | Neutral | 18.535.951 $ | +2.801.040 $ | +17,8 % | 1 | 15.734.911 $ | +4.235.356 $ | +36,8 % | 1 | 11.499.555 $ | +5.230.333 $ | +83,4 % | 1 |
| Immunome Inc. | IMNM | → 0 | Neutral | 16.020.037 $ | +285.679 $ | +1,8 % | 1 | 15.734.358 $ | +9.849.942 $ | +167,4 % | 1 | 5.884.416 $ | +5.884.416 $ | 1 | |
| MapLight Therapeutics, Inc. | MPLT | → 0 | Schwach | 12.430.718 $ | +1.687.594 $ | +15,7 % | 1 | 10.743.124 $ | +10.743.124 $ | 1 | |||||
| BioAge Labs, Inc. | BIOA | → 0 | Neutral | 11.427.511 $ | +2.783.373 $ | +32,2 % | 1 | 8.644.138 $ | +4.802.299 $ | +125,0 % | 1 | ||||
| Avalo Therapeutics, Inc. | AVTX | → 0 | Schwach | 4.418.280 $ | +4.418.280 $ | 1 | |||||||||
| 275.081.499 $ | +21.025.560 $ | +6,6 % | 10 | 254.055.939 $ | +85.681.398 $ | +56,3 % | 9 | 164.532.702 $ | +33.897.375 $ | +50,8 % | 6 | ||||